Emcure Pharmaceuticals Ltd reported a steady set of Q4 FY26 earnings on May 5, with profit growth led by healthy international business momentum and...
Emcure Pharmaceuticals Ltd has announced a sharp reduction in the starting dose price of its weight management drug Poviztra, aiming to expand patient access...
Emcure Pharmaceuticals reported a strong set of December-quarter earnings, with consolidated net profit jumping 50% year-on-year to ₹230.5 crore, aided by robust revenue growth...